Bio-Rad Executives to Participate in Investor Conferences

miércoles, 27 de agosto de 2025, 6:59 am ET1 min de lectura
MS--
WFC--

Bio-Rad Laboratories' executive leadership will participate in upcoming investor conferences, including the 2025 Wells Fargo Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference. Norman Schwartz, Chairman and CEO, and Roop K. Lakkaraju, CFO, will engage in fireside chats and one-on-one investor meetings. The company reported $2.6 billion in revenues for 2024 and maintains a significant market presence with a market capitalization of $7.80 billion.

Bio-Rad Executives to Participate in Investor Conferences

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios